Assistance Publique - Hôpitaux de Paris: Precursor Cell Lymphoblastic Leukemia-Lymphoma trials
The registry lists 18 Precursor Cell Lymphoblastic Leukemia-Lymphoma studies with Assistance Publique - Hôpitaux de Paris as lead sponsor. 8 are open to participants now and 0 have results posted.
Phase 1 3Phase 2 8Phase 3 5No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Study of Cell-free DNA in Children and Adolescents With Acute Lymphoblastic LeukemiaRecruitingNCT07483476
- A 3-cohort Randomized Study Evaluating the Role of New Immunotherapeutic Agents and of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Frontline Therapy of Adults With Acute Lymphoblastic LeukemiaRecruitingNCT06860269Phase 2/3
- Early Assessment of Cardiac Function After Treatment With CAR-T CellsRecruitingNCT06350994
- The Patient Cohort of the National Center for Precision Medicine in LeukemiaRecruitingNCT05326919
- Combination of an Anti-PD1 Antibody With Tisagenlecleucel Reinfusion in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia After Loss of PersistenceRecruitingNCT05310591Phase 1/2
- Multicenter Study of Risk-adapted Treatment for T-lineage ALL of Young Adults (18-59 Years Old)RecruitingNCT02619630Phase 2
- Multicenter Trial Treatment of Philadelphia Chromosome Negative B-cell Acute Lymphoblastic Leukemia of Young AdultsRecruitingNCT02617004
- A Phase III Randomized Trial of the Reduction of Chemotherapy in Philadelphia Chromosome-positive ALL of Young AdultsRecruitingNCT02611492Phase 3
- Efficacy of Osteopathic Treatment on the Side Effects of Curative Treatments of Lymphoblastic Leukemia in PediatricsStatus unknownNCT05664230
- Anti-Covid-19 Vaccine in Children With Acute Leukemia and Their SiblingsCompletedNCT04969601Phase 1/2
- Evaluation of Long-term Health Status and Quality of Life in Adult Survivors With Philadelphia-negative Acute Lymphoblastic Leukemia/Lymphoma Treated With an Intensive Pediatric or Pediatric-inspired ProtocolStatus unknownNCT04677231
- ETOILE : A Feasibility Study in Pediatric Patient EducationCompletedNCT04399863Not applicable
- Evaluation of a Donor Testing Kit for the Prediction of AGVHD in Patient Receiving a Peripheral Blood Stem Cell AllograftStatus unknownNCT03887156Phase 2/3
- Blinatumomab in High-risk B-cell Precursor Acute Lymphoblastic LeukemiaActive, not recruitingNCT03709719Phase 2
- HLA 10/10 Matched Unrelated Donor vs Haploidentical Allogenic Hematopoietic Stem Cell TransplantationStatus unknownNCT03655145Phase 3
- A French Protocol for the Treatment of Acute Lymphoblastic Leukemia (ALL) in Children and AdolescentsActive, not recruitingNCT02716233Phase 3
- Alemtuzumab (CAMPATH 1H) Associated to G-CSF in Adult Patients With Refractory Acute Lymphocytic LeukemiaCompletedNCT00773149Phase 1/2
- Imatinib Mesylate With Vincristine and Dexamethasone in Acute Lymphoblastic Leukemias With BCR-ABL PositiveCompletedNCT00763763Phase 2